DOCSLIB.ORG

Unterschleißheim, 27

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Unterschleißheim, 27 Program BAADER HELVEA SWISS EQUITIES CONFERENCE 10 – 11 January 2019 Grand Resort Bad Ragaz, Switzerland CONTACTS @ BAADER HELVEA Lukas Burkart, Head of Equity Sales T +49 89 5150 1858, [email protected] Andreas von Arx, Head of Equity Research Switzerland T +41 43 388 9257, [email protected] Reto Amstalden, Equity Research T +41 43 388 9261, [email protected] www.baaderbank.com Enable Change in Banking. Baader Helvea Swiss Equities Conference 10 – 11 January 2019 PRESENTING COMPANIES 67 companies have agreed to participate in the Swiss Equities Conference 2019: Bloomberg Reuters Company name ticker ticker Sector Addex Therapeutics ADXN SE ADXN.S Pharma & Healthcare Adecco Group ADEN SE ADEN.S Business Services & Logistics ARBONIA ARBN SE ARBNO.S Construction Ascom ASCN SE ASCN.S Technology Baloise BALN SE BALN.S Banks & Insurance Basilea (one-on-one only) BSLN SE BSLN.S Pharma & Healthcare BB Biotech (one-on-one only) BION SW BION.S Pharma & Healthcare BKW AG BKW SE BKWB.S Utilities Bossard BOSN SE BOS.S Industrials Bucher Industries BUCN SE BUCN.S Industrials Cembra Money Bank CMBN SE CMBN.S Banks & Insurance Clariant CLN SE CLN.S Chemicals COLTENE CLTN SE CLTN.S Pharma & Healthcare Compagnie Financière Tradition (one-on-one only) CFT SE CFT.S Banks & Insurance Conzzeta CON SE CONC.S Industrials Dätwyler Holding Inc. DAE SE DAE.S Technology dormakaba DOKA SE DOKA.S Industrials Dufry DUFN SE DUFN.S Consumer & Retail EFG International EFGN SE EFGN.S Banks & Insurance Evolva (one-on-one only) EVE SE EVE.S Chemicals Galenica GALE SE GALE.S Consumer & Retail GAM Holding (one-on-one only) GAM SE GAM.S Banks & Insurance Geberit GEBN SE GEBN.S Industrials Givaudan GIVN SE GIVN.S Consumer & Retail Gurit GUR SE GUR.S Chemicals HBM Healthcare Investments AG (one-on-one only) HBMN SE HBMN.S Pharma & Healthcare Helvetia (one-on-one only) Heln SE HELN.S Banks & Insurance Huber+Suhner HUBN SE HUBN.S Technology Idorsia IDIA SE IDIA.S Pharma & Healthcare Inficon IFCN SE IFCN.S Industrials Komax KOMN SE KOMN.S Industrials Kuehne + Nagel KNIN SE KNIN.S Business Services & Logistics LafargeHolcim LHN SW LHN.S Construction Landis+Gyr LAND SE LANDI.S Technology Lonza Group LONN SE LONN.S Chemicals 2 www.swissequitiesconference.com Baader Helvea Swiss Equities Conference 10 – 11 January 2019 PRESENTING COMPANIES 67 companies have agreed to participate in the Swiss Equities Conference 2019: Bloomberg Reuters Company name ticker ticker Sector Metall Zug (one-on-one only) METN SE METN.S Industrials Molecular Partners (one-on-one only) MOLN SE MOLN.S Pharma & Healthcare OC Oerlikon OERL SE OERL.S Industrials Orascom ODHN SE ODHN.S Real Estate ORIOR ORON SE ORON.S Consumer & Retail Panalpina (one-on-one only) PWTN SE PWTN.S Business Services & Logistics Partners Group PGHN SE PGHN.S Banks & Insurance Rieter Management AG RIEN SE RIEN.S Consumer & Retail Roche ROG SE ROG.S Pharma & Healthcare SCHMOLZ + BICKENBACH AG (one-on-one only) STLN SE STLN.S Basic Resources Schweiter Technologies SWTQ SE SWTQ.S Technology SENSIRION SENS SE SENSI.S Technology SFS Group SFSN SE SFSN.S Industrials Siegfried Holding SFZN SE SFZN.S Chemicals Sika SIKA SE SIKA.S Chemicals Sonova SOON SE SOON.S Pharma & Healthcare Straumann STMN SE STMN.S Pharma & Healthcare Sulzer SUN SE SUN.S Industrials Swiss Life SLHN SE SLHN.S Banks & Insurance Swissquote SQN SE SQN.S Banks & Insurance Swiss Re SREN SE SRENH.S Banks & Insurance Tamedia TAMN SE TAMN.S Consumer & Retail u-blox UBXN SE UBXN.S Technology Valiant VATN SE VATN.S Banks & Insurance Valora VALN SE VALN.S Consumer & Retail VAT Group VACN SE VACN.S Industrials Vetropack (one-on-one only) VET SE VET.S Industrials Vifor Pharma VIFN SE VIFN.S Pharma & Healthcare Vontobel VONN SE VONN.S Banks & Insurance VZ Holding (one-on-one only) VZN SE VZN.S Banks & Insurance Zur Rose Group AG (one-on-one only) ROSE SE ROSEG.S Consumer & Retail Zurich Insurance Group (one-on-one only) ZURN SE ZURN.S Banks & Insurance As of 10 January 2019 www.swissequitiesconference.com 3 Baader Helvea Swiss Equities Conference 10 – 11 January 2019 PRESENTATIONS – THURSDAY, 10 JANUARY 2019 08:00 Coffee & registration TRACK 1 TRACK 2 TRACK 3 08:30 – 09:15 Sonova Gurit COLTENE Hartwig Grevener, CFO Rudolf Hadorn, CEO Gerhard Mahrle, CFO Angelo Quabba, CFO Martin Schaufelberger, CEO 09:20 – 10:05 Sika Rieter Management AG Geberit Adrian Widmer, CFO Norbert Klapper, CEO Christian Buhl, CEO Dominik Slappnig, Joris Gröflin, CFO Head of CC & IR 10:10 Coffee break 10:30 – 11:15 Lonza Group Swiss Life Roche Sven Abend, COO Lonza Thomas Buess, CFO Dr. Michael Heuer, CEO Specialty Ingredients Matthias Aellig, CRO Roche Diagnostics Dr. Kristin Köhler, IR 11:20 – 12:05 Komax Siegfried Holding Baloise Matijas Meyer, CEO Dr. Wolfgang Wienand, Carsten Stolz, CFO Roger Müller, CEO Markus Holtz, IR Head of IR & CC Dr. Reto Suter, CFO 12:10 – 12:55 OC Oerlikon BKW AG Cembra Money Bank Jürg Fedier, CFO Ronald Trächsel, CFO Robert Oudmayer, CEO Franziska Stein, IR Thomas Herren, IR Pascal Perritaz, CFO 13:00 Lunch 14:15 – 15:00 Sulzer Orascom EFG International Greg Poux-Guillaume, CEO Khaled Bichara, CEO Dimitris Politis, CFO Christoph Ladner, Head of IR Ashraf Nessim, CFO Jens Brueckner, Head of IR 15:05 – 15:50 Clariant Landis+Gyr Bucher Industries Patrick Jany, CFO Richard Mora, CEO Jacques Sanche, CEO Dr. Anja Pomrehn, Head of IR Christian Waelti, IR Manuela Suter, CFO 15:55 Coffee break 16:15 – 17:00 Bossard Dufry Vontobel David Dean, Group CEO Andreas Schneiter, CFO Zeno Staub, CEO Stephan Zehnder, Group CFO Renzo Radice, Global Head Michèle Schnyder, Head of IR IR & CC 17:05 – 17:50 LafargeHolcim Ascom Schweiter Technologies Jan Jenisch, CEO Holger Cordes, CEO Dr. Heinz O. Baumgartner, Swetlana Iodko, Head of IR Dr. Daniel Lack, Senior VP CEO Legal & Communications / IR 17:50 End 4 www.swissequitiesconference.com Baader Helvea Swiss Equities Conference 10 – 11 January 2019 PRESENTATIONS – FRIDAY, 11 JANUARY 2019 08:00 Coffee & registration TRACK 1 TRACK 2 TRACK 3 08:15 – 09:00 Kuehne + Nagel Partners Group Inficon Markus Blanka-Graff, CFO Philip Sauer, Co-Head Group Lukas Winkler, CEO Christopher Combé, Finance & Corporate Head of IR Development Alex Soppera, Corporate Development 09:05 – 09:50 SFS Group Huber+Suhner Conzzeta Jens Breu, CEO Urs Ryffel, CEO Michael Willome, Claude Stadler, Ivo Wechsler, CFO Group CEO Conzzeta Head of CC & IR Michael Staeheli, Head of IR & CC 09:55 Coffee break 10:10 – 10:55 Straumann SENSIRION ORIOR Dr. Peter Hackel, CFO Dr. Marc von Waldkirch, CEO Daniel Lutz, CEO Fabian Hildbrand, Head of Dr. Andrea Wüest, Milena Mathiuet, Investor Communications & Director IR and M&A Head of CC & IR Market Analysis 11:00 – 11:45 dormakaba Idorsia Swissquote Riet Cadonau, Andrew C. Weiss, Michael Ploog, CFO Chairman & CEO Member of Leadership Siegfried Schwirzer, Team/Head of IR & CC Head of IR 11:50 – 12:35 VAT Group Swiss Re Tamedia Mike Allison, CEO Martin Müller, Corporate Christoph Tonini, CEO Michel Gerber, Solutions CFO Head of CC & IR Daniel Bischof, IR 12:40 – 13:25 Addex Therapeutics (Presentation Tim Dyer, CEO parallel to lunch) 12:35 Lunch 13:35 – 14:20 Givaudan Galenica ARBONIA Tom Hallam, CFO Felix Burkhard, CFO Alexander von Witzleben, CEO Peter Wullschleger, Head of IR Fabienne Zürcher, Head of CC 14:25 – 15:10 Dätwyler Holding Inc. Vifor Pharma Valora Reto Welte, CFO Colin Bond, CFO Tobias Knechtle, CFO Annette Martin, Head of IR 15:15 – 16:00 Adecco Group u-blox Valiant Hans Ploos van Amstel, CFO Thomas Seiler, CEO Markus Gygax, CEO Nicholas de la Grense, Joachim Matha, Head of IR Head of IR 16:00 End www.swissequitiesconference.com 5 Baader Helvea Swiss Equities Conference 10 – 11 January 2019 ONE-ON-ONE MEETINGS ONLY 10 JANUARY 2019 . BB Biotech . u-blox Dr. Silvia Siegfried-Schanz, IR Thomas Seiler, CEO . Conzzeta . VZ Holding Michael Willome, Rafael Pfaffen, CFO Group CEO Conzzeta . Zur Rose Group AG Michael Staeheli, Marcel Ziwica, CFO Head of IR & CC . Zurich Insurance Group . Givaudan Gianni Vitale, IR Tom Hallam, CFO Samuel Han, IR Peter Wullschleger, Head of IR . HBM Healthcare Investments AG Erwin Troxler, CFO Dr. Dominique Küttel, Head BD 11 JANUARY 2019 . Basilea . LafargeHolcim Dr. Laurenz Kellenberger, Chief Scientific Officer Jan Jenisch, CEO Dr. Peer Nils Schröder, Head of CC & IR Swetlana Iodko, Head of IR . Bossard . Metall Zug David Dean, Group CEO Dr. Jürg Werner, CEO Stephan Zehnder, Group CFO Daniel Keist, CFO . Bucher Industries . Molecular Partners Jacques Sanche, CEO Andreas Emmenegger, CFO Manuela Suter, CFO Thomas Schneckenburger, Head of IR . Compagnie Financière Tradition . Panalpina Patrick Combes, CEO Robert Erni, CFO François Brisebois, Group CFO . SCHMOLZ + BICKENBACH AG . Evolva, Matthias Wellhausen, CFO Oliver Walker, CEO Dr. Ulrich Steiner, Head of IR & CC Paul Verbraeken, Head of IR . Schweiter Technologies . GAM Holding Dr. Heinz O. Baumgartner, CEO Patrick Zuppiger, Head of IR . Vetropack Jessica Grassi, IR David Zak, CFO . Helvetia Paul Norton, CFO Susanne Tengler, Head of IR 6 www.swissequitiesconference.com Baader Helvea Swiss Equities Conference 10 – 11 January 2019 EVENING EVENT DATE START EVENING VENUE DRESSCODE Wednesday, 19:00 Informal Dinner Business Casual 9 JANUARY 2019 Grand Resort Bad Ragaz Restaurant "Bel-Air" Bernhard-Simonstrasse 7310 Bad Ragaz Switzerland Thursday, 19:30 Aperitif & Gala-Dinner Business 10 JANUARY 2019 Grand Hotel Hof Ragaz Restaurant "Olives d'Or" Bernhard-Simonstrasse 7310 Bad Ragaz Switzerland CONTACT DETAILS For Investors Equity Sales Tanja Großschädl Lukas Burkart T +49 89 5150 1884 T +49 89 5150 1858 [email protected] [email protected] For Companies Equity Research Katja Wilke Reto Amstalden Andreas von Arx T +49 89 5150 1886 T +41 43 388 9261 T +41 43 388 9257 [email protected] [email protected] [email protected] www.swissequitiesconference.com 7 Baader Helvea Swiss Equities Conference 10 – 11 January 2019 www.baaderbank.com Enable Change in Banking.
Load more

Recommended publications
  • Market Notice Date: 14 November 2019 Market Notice Number: 112/2019
    Market Notice Date: 14 November 2019 Market Notice Number: 112/2019 Equiduct Universe Change Please see today's changes below effective 18 November 2019: Trading Reporting MIC Settlement Trading Settlement Tick Size Change/ Security Name ISIN Home Market Symbol Country Currency Currency table Action ABB LTD ABBNz CH0012221716 XSWX EQTB CH CHF CHF ESMA_E Deletion ABB ABBs CH0012221716 XSTO EQTB SE SEK SEK ESMA_E Deletion ADECCO SA ADENz CH0012138605 XSWX EQTC CH CHF CHF ESMA_E Deletion AMS AG AMSz AT0000A18XM4 XSWX EQTC CH CHF CHF ESMA_E Deletion ARYZTA AG ARYNz CH0043238366 XSWX EQTB CH CHF CHF ESMA_E Deletion JULIUS BAER GRUPPE AG BAERz CH0102484968 XSWX EQTC CH CHF CHF ESMA_E Deletion BALOISE-HLDGS BALNz CH0012410517 XSWX EQTC CH CHF CHF ESMA_D Deletion BARRY CALLEBAUT AG BARNz CH0009002962 XSWX EQTC CH CHF CHF ESMA_D Deletion BB BIOTECH BBZAd CH0038389992 XETR EQTB DE EUR EUR ESMA_D Deletion BB BIOTECH BIONz CH0038389992 XSWX EQTB CH CHF CHF ESMA_D Deletion BASILEA PHARMACEUTICA AG BSLNz CH0011432447 XSWX EQTC CH CHF CHF ESMA_D Deletion BUCHER INDUSTRIES BUCNz CH0002432174 XSWX EQTC CH CHF CHF ESMA_D Deletion COMPAGNIE FINANCIERE RICHEMONT CFRz CH0210483332 XSWX EQTC CH CHF CHF ESMA_E Deletion CLARIANT CLNz CH0012142631 XSWX EQTC CH CHF CHF ESMA_E Deletion CEMBRA MONEY BANK AG CMBNz CH0225173167 XSWX EQTC CH CHF CHF ESMA_D Deletion CREDIT SUISSE GROUP AG CSGNz CH0012138530 XSWX EQTC CH CHF CHF ESMA_E Deletion DKSH HOLDING DKSHz CH0126673539 XSWX EQTC CH CHF CHF ESMA_D Deletion DORMA+KABA HOLDING AG DOKAz CH0011795959 XSWX EQTC CH CHF
    [Show full text]
  • Contract Specifications for Futures Contracts and Eurex14 Options Contracts at Eurex Deutschland and Stand March 2831, 2008 Eurex Zürich Seite 1
    Contract Specifications for Futures Contracts and Eurex14 Options Contracts at Eurex Deutschland and Stand March 2831, 2008 Eurex Zürich Seite 1 [....] Annex A in relation to subsection 1.6 of the contract specifications: Futures on Shares of Produkt- Group Cash Contract Minimum Currency ID ID** Market- Size Price ID** Change* Julius Bär Holding AG - N. BAEG CH01 XSWX 50 0.0010.01 CHF BB Biotech AG BIOF CH01 XSWX 50 0.0010.01 CHF Logitech International S.A. - N. LOGF CH01 XSWX 100 0.00010.01 CHF Pargesa Holding S.A. PARF CH01 XSWX 10 0.0010.01 CHF Sonova Holding AG - N. PHBF CH01 XSWX 50 0.0010.01 CHF PSP Swiss Property AG - N. PSPF CH01 XSWX 50 0.0010.01 CHF Schindler Holding AG SINF CH01 XSWX 50 0.0010.01 CHF Straumann Holding AG STMF CH01 XSWX 10 0.0010.01 CHF Swatch Group AG, The - N. UHRF CH01 XSWX 100 0.00010.01 CHF Valiant Holding AG - N. VATF CH01 XSWX 10 0.0010.01 CHF ABB Ltd. ABBF CH02 XVTX 100 0.00010.01 CHF Adecco S.A. - N. ADEF CH02 XVTX 100 0.0010.01 CHF Actelion Ltd. - N. ATLG CH02 XVTX 50 0.0010.01 CHF Bâloise Holding AG BALF CH02 XVTX 100 0.0010.01 CHF Compagnie Financière Richemont AG CFRH CH02 XVTX 100 0.0010.01 CHF Ciba Spezialitätenchemie Holding AG - N. CIBF CH02 XVTX 10 0.0010.01 CHF Clariant AG - N. CLNF CH02 XVTX 100 0.00010.01 CHF Credit Suisse Group - N. CSGG CH02 XVTX 100 0.00010.01 CHF Geberit AG - N.
    [Show full text]
  • Remuneration
    REMUNERATION 124 Vifor Pharma Ltd. Annual Report 2020 HIGHLIGHTS PEOPLE 126 Chairwoman’s overview 128 Philosophy and approach to remuneration 130 Governance 134 Board and Executive remuneration 139 Remuneration awarded in 2020 and 2019 146 Overview of executive remuneration in 2020 and 2019 147 Outlook: changes in remuneration model for 2021 148 Statutory auditor’s report PORTFOLIO RESPONSIBILITY GOVERNANCE REMUNERATION FINANCE Vifor Pharma Ltd. Annual Report 2020 125 REMUNERATION CHAIRWOMAN’S OVERVIEW The remuneration “programs of Vifor Pharma are designed to support our corporate strategy and to ensure a sustainable performance towards our future objectives.” SUE MAHONY CHAIRWOMAN OF THE REMUNERATION COMMITTEE 126 Vifor Pharma Ltd. Annual Report 2020 HIGHLIGHTS “ We reward entrepreneurial Vifor Pharma’s remuneration philosophy aims to attract and retain highly talented and behaviour that ethical individuals who help us ensure the drives sustainable long-term competitiveness and success of our PEOPLE business, to meet the needs of patients, to performance and look after the interests of our stakeholders and the environment in order to deliver on the long-term value strategy and to sustain profitable growth. This report sets out the remuneration policies for creation.” the Board of Directors and Executive Commit- tee which are designed to help them achieve these goals. A year of unprecedented challenges for Chief Medical Officer and Gregory Oakes as countries and companies around the world President North America. PORTFOLIO has underlined the importance of a strong and transparent remuneration framework. The Remuneration Committee considers Vifor Notwithstanding, as in previous years, Vifor Pharma appropriately positioned to enable it Pharma’s philosophy and approach to remu- to compete successfully with its peers and to neration has remained stable: we reward support its ambitious growth plans.
    [Show full text]
  • Switzerland Fund A-CHF for Investment Professionals Only FIDELITY FUNDS MONTHLY PROFESSIONAL FACTSHEET SWITZERLAND FUND A-CHF 31 AUGUST 2021
    pro.en.xx.20210831.LU0054754816.pdf Switzerland Fund A-CHF For Investment Professionals Only FIDELITY FUNDS MONTHLY PROFESSIONAL FACTSHEET SWITZERLAND FUND A-CHF 31 AUGUST 2021 Strategy Fund Facts The Portfolio Managers are bottom-up investors who believe share prices are Launch date: 13.02.95 correlated to earnings, and that strong earners will therefore outperform. They look to Portfolio manager: Andrea Fornoni, Alberto Chiandetti invest in companies where the market underestimates earnings because their Appointed to fund: 01.03.18, 01.08.11 sustainability is not fully appreciated. They also look for situations where the impact Years at Fidelity: 7, 15 company changes will have on earnings has not been fully recognised by the market. Fund size: CHF366m They aim to achieve a balance of different types of companies, so they can deliver Number of positions in fund*: 36 performance without adding undue risk. Fund reference currency: Swiss Franc (CHF) Fund domicile: Luxembourg Fund legal structure: SICAV Management company: FIL Investment Management (Luxembourg) S.A. Capital guarantee: No Portfolio Turnover Cost (PTC): 0.01% Portfolio Turnover Rate (PTR): 28.92% *A definition of positions can be found on page 3 of this factsheet in the section titled “How data is calculated and presented.” Objectives & Investment Policy Share Class Facts • The fund aims to provide long-term capital growth with the level of income expected Other share classes may be available. Please refer to the prospectus for more details. to be low. • The fund will invest at least 70% in Swiss company shares. Launch date: 13.02.95 • The fund has the freedom to invest outside its principal geographies, market sectors, industries or asset classes.
    [Show full text]
  • FTSE Publications
    2 FTSE Russell Publications FTSE Developed Europe SMID Cap 19 August 2021 Tradable Plus Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 3i Group 0.72 UNITED Bureau Veritas S.A. 0.42 FRANCE Gjensidige Forsikring ASA 0.17 NORWAY KINGDOM Campari 0.31 ITALY Gn Store Nordic 0.53 DENMARK AAK 0.18 SWEDEN Carl Zeiss Meditec 0.33 GERMANY Halma 0.66 UNITED Aalberts NV 0.24 NETHERLANDS Castellum 0.32 SWEDEN KINGDOM ABN AMRO Bank NV 0.23 NETHERLANDS Centrica 0.2 UNITED Hargreaves Lansdown 0.39 UNITED Acciona S.A. 0.16 SPAIN KINGDOM KINGDOM Accor 0.32 FRANCE Chr. Hansen Holding A/S 0.43 DENMARK Hays 0.16 UNITED ACS Actividades Cons y Serv 0.3 SPAIN Clariant 0.21 SWITZERLAND KINGDOM Adecco Group AG 0.49 SWITZERLAND Coca-Cola HBC AG 0.33 UNITED HeidelbergCement AG 0.6 GERMANY Adevinta 0.21 NORWAY KINGDOM HelloFresh SE 0.67 GERMANY Admiral Group 0.43 UNITED Cofinimmo 0.21 BELGIUM Helvetia Holding AG 0.18 SWITZERLAND KINGDOM Commerzbank 0.35 GERMANY Hikma Pharmaceuticals 0.27 UNITED Aedifica 0.22 BELGIUM ConvaTec Group 0.25 UNITED KINGDOM Aegon NV 0.34 NETHERLANDS KINGDOM Hiscox 0.18 UNITED KINGDOM Aeroports de Paris 0.17 FRANCE Countryside Properties 0.16 UNITED Holmen AB 0.2 SWEDEN Ageas 0.46 BELGIUM KINGDOM Homeserve 0.17 UNITED Aker BP ASA 0.16 NORWAY Covestro AG 0.54 GERMANY KINGDOM Alfa Laval 0.52 SWEDEN Covivio 0.2 FRANCE Howden Joinery Group 0.3 UNITED Alstom 0.7 FRANCE Croda International 0.64 UNITED KINGDOM KINGDOM Alten 0.18
    [Show full text]
  • Keyinvest Return Monitor Systematically Selected UBS Barrier Reverse Convertibles
    Structured investment products for clients in Switzerland KeyInvest Return Monitor Systematically selected UBS Barrier Reverse Convertibles The Return Monitor provides an overview of UBS Barrier Reverse Convertibles (BRCs) offering attractive potential returns. All selected BRCs are listed on the SIX Structured Products Exchange and tradeable on each trading day under normal market conditions. In focus are products that have at least three months left until maturity and an intact barrier. The three categories examined are: Attractive sideways return, high barrier distance and underlyings with a Buy Rating by UBS Research. Further information can be found on: ubs.com/renditemonitor Attractive sideways return Barrier distance Coupon p.a. Underlying Ask Currency Expiry Valor Sideways return p.a. (worst performer) 5.50% Bayer / Novartis / Roche / Sanofi 74.30 CHF 14/08/2020 A 39945568 15.1% 30.6% 8.00% CENTRICA PLC / E.ON / Electricite de France 78.70 EUR 10/08/2020 A 42686847 18.7% 28.2% 9.00% Credit Suisse / Deutsche Bank 82.10 CHF 13/07/2020 A 42078534 15.8% 26.3% 9.75% Enel / Fiat Chrysler / UniCredit 85.20 EUR 29/06/2020 39167120 28.3% 23.9% 9.00% Hewlett-Packard / IBM 93.27 USD 06/07/2020 A 42271711 31.2% 15.1% High barrier distance Barrier distance Coupon p.a. Underlying Ask Currency Expiry Valor Sideways return p.a. (worst performer) 12.00% Alcoa Corporation / US STEEL CORP 96.32 USD 12/06/2020 A 44506090 47.5% 15.3% 7.75% Colgate-Palmolive / Estée Lauder / L'Oréal 98.55 USD 22/06/2020 A 41905920 43.9% 15.4% 10.00% Nike / Under Armour Inc.
    [Show full text]
  • Portfolio of Investments
    PORTFOLIO OF INVESTMENTS Variable Portfolio – Partners International Value Fund, September 30, 2020 (Unaudited) (Percentages represent value of investments compared to net assets) Investments in securities Common Stocks 97.9% Common Stocks (continued) Issuer Shares Value ($) Issuer Shares Value ($) Australia 4.2% UCB SA 3,232 367,070 AMP Ltd. 247,119 232,705 Total 13,350,657 Aurizon Holdings Ltd. 64,744 199,177 China 0.6% Australia & New Zealand Banking Group Ltd. 340,950 4,253,691 Baidu, Inc., ADR(a) 15,000 1,898,850 Bendigo & Adelaide Bank Ltd. 30,812 134,198 China Mobile Ltd. 658,000 4,223,890 BlueScope Steel Ltd. 132,090 1,217,053 Total 6,122,740 Boral Ltd. 177,752 587,387 Denmark 1.9% Challenger Ltd. 802,400 2,232,907 AP Moller - Maersk A/S, Class A 160 234,206 Cleanaway Waste Management Ltd. 273,032 412,273 AP Moller - Maersk A/S, Class B 3,945 6,236,577 Crown Resorts Ltd. 31,489 200,032 Carlsberg A/S, Class B 12,199 1,643,476 Fortescue Metals Group Ltd. 194,057 2,279,787 Danske Bank A/S(a) 35,892 485,479 Harvey Norman Holdings Ltd. 144,797 471,278 Demant A/S(a) 8,210 257,475 Incitec Pivot Ltd. 377,247 552,746 Drilling Co. of 1972 A/S (The)(a) 40,700 879,052 LendLease Group 485,961 3,882,083 DSV PANALPINA A/S 15,851 2,571,083 Macquarie Group Ltd. 65,800 5,703,825 Genmab A/S(a) 1,071 388,672 National Australia Bank Ltd.
    [Show full text]
  • Global Equity Fund Description Plan 3S DCP & JRA MICROSOFT CORP
    Global Equity Fund June 30, 2020 Note: Numbers may not always add up due to rounding. % Invested For Each Plan Description Plan 3s DCP & JRA MICROSOFT CORP 2.5289% 2.5289% APPLE INC 2.4756% 2.4756% AMAZON COM INC 1.9411% 1.9411% FACEBOOK CLASS A INC 0.9048% 0.9048% ALPHABET INC CLASS A 0.7033% 0.7033% ALPHABET INC CLASS C 0.6978% 0.6978% ALIBABA GROUP HOLDING ADR REPRESEN 0.6724% 0.6724% JOHNSON & JOHNSON 0.6151% 0.6151% TENCENT HOLDINGS LTD 0.6124% 0.6124% BERKSHIRE HATHAWAY INC CLASS B 0.5765% 0.5765% NESTLE SA 0.5428% 0.5428% VISA INC CLASS A 0.5408% 0.5408% PROCTER & GAMBLE 0.4838% 0.4838% JPMORGAN CHASE & CO 0.4730% 0.4730% UNITEDHEALTH GROUP INC 0.4619% 0.4619% ISHARES RUSSELL 3000 ETF 0.4525% 0.4525% HOME DEPOT INC 0.4463% 0.4463% TAIWAN SEMICONDUCTOR MANUFACTURING 0.4337% 0.4337% MASTERCARD INC CLASS A 0.4325% 0.4325% INTEL CORPORATION CORP 0.4207% 0.4207% SHORT-TERM INVESTMENT FUND 0.4158% 0.4158% ROCHE HOLDING PAR AG 0.4017% 0.4017% VERIZON COMMUNICATIONS INC 0.3792% 0.3792% NVIDIA CORP 0.3721% 0.3721% AT&T INC 0.3583% 0.3583% SAMSUNG ELECTRONICS LTD 0.3483% 0.3483% ADOBE INC 0.3473% 0.3473% PAYPAL HOLDINGS INC 0.3395% 0.3395% WALT DISNEY 0.3342% 0.3342% CISCO SYSTEMS INC 0.3283% 0.3283% MERCK & CO INC 0.3242% 0.3242% NETFLIX INC 0.3213% 0.3213% EXXON MOBIL CORP 0.3138% 0.3138% NOVARTIS AG 0.3084% 0.3084% BANK OF AMERICA CORP 0.3046% 0.3046% PEPSICO INC 0.3036% 0.3036% PFIZER INC 0.3020% 0.3020% COMCAST CORP CLASS A 0.2929% 0.2929% COCA-COLA 0.2872% 0.2872% ABBVIE INC 0.2870% 0.2870% CHEVRON CORP 0.2767% 0.2767% WALMART INC 0.2767%
    [Show full text]
  • 2019 Switzerland Spencer Stuart Board Index 
    2019 Switzerland Spencer Stuart Board Index About Spencer StuArt Spencer Stuart has had an uninterrupted presence in Switzerland since 1959, when it opened its Zurich office. Spencer Stuart is one of the world’s leading executive search consulting firms. We are trusted by organisations around the world to help them make the senior-level leadership decisions that have a lasting impact on their enterprises. Through our executive search, board and leadership advisory services, we help build and enhance high-performing teams for select clients ranging from major multinationals to emerging companies to nonprofit institutions. Privately held since 1956, we focus on delivering knowledge, insight and results though the collaborative efforts of a team of experts — now spanning more than 60 offices, over 30 countries and more than 50 practice specialties. Boards and leaders consistently turn to Spencer Stuart to help address their evolving leadership needs in areas such as senior-level executive search, board recruitment, board effectiveness, succession planning, in-depth senior management assessment and many other facets of organisational effectiveness. For more information on Spencer Stuart, please visit www.spencerstuart.com. Social Media @ Spencer Stuart Stay up to date on the trends and topics that are relevant to your business and career. @Spencer Stuart © 2020 Spencer Stuart. All rights reserved. For information about copying, distributing and displaying this work, contact: [email protected]. 1 spencer stuart Contents 3 Foreword
    [Show full text]
  • FTSE Developed Europe
    2 FTSE Russell Publications 19 August 2021 FTSE Developed Europe Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 1&1 AG 0.01 GERMANY Avast 0.03 UNITED Cnp Assurance 0.02 FRANCE 3i Group 0.14 UNITED KINGDOM Coca-Cola HBC AG 0.06 UNITED KINGDOM Aveva Group 0.05 UNITED KINGDOM A P Moller - Maersk A 0.1 DENMARK KINGDOM Coloplast B 0.19 DENMARK A P Moller - Maersk B 0.15 DENMARK Aviva 0.19 UNITED Colruyt 0.03 BELGIUM A2A 0.03 ITALY KINGDOM Commerzbank 0.07 GERMANY Aalberts NV 0.05 NETHERLANDS AXA 0.43 FRANCE Compagnie Financiere Richemont SA 0.55 SWITZERLAND ABB 0.51 SWITZERLAND B&M European Value Retail 0.06 UNITED Compass Group 0.33 UNITED KINGDOM ABN AMRO Bank NV 0.04 NETHERLANDS KINGDOM BAE Systems 0.21 UNITED Acciona S.A. 0.03 SPAIN Continental 0.14 GERMANY KINGDOM Accor 0.06 FRANCE ConvaTec Group 0.05 UNITED Baloise 0.06 SWITZERLAND Ackermans & Van Haaren 0.03 BELGIUM KINGDOM Banca Mediolanum 0.02 ITALY ACS Actividades Cons y Serv 0.06 SPAIN Covestro AG 0.1 GERMANY Banco Bilbao Vizcaya Argentaria 0.36 SPAIN Adecco Group AG 0.09 SWITZERLAND Covivio 0.04 FRANCE Banco Santander 0.58 SPAIN Adevinta 0.04 NORWAY Credit Agricole 0.14 FRANCE Bank Pekao 0.03 POLAND Adidas 0.63 GERMANY Credit Suisse Group 0.22 SWITZERLAND Bankinter 0.03 SPAIN Admiral Group 0.08 UNITED CRH 0.35 UNITED Banque Cantonale Vaudoise 0.02 SWITZERLAND KINGDOM KINGDOM Barclays 0.35 UNITED Adyen 0.62 NETHERLANDS Croda International 0.12 UNITED KINGDOM KINGDOM Aegon NV 0.06 NETHERLANDS Barratt Developments 0.09 UNITED Cts Eventim 0.03 GERMANY Aena SME SA 0.1 SPAIN KINGDOM Cyfrowy Polsat SA 0.02 POLAND Aeroports de Paris 0.03 FRANCE Barry Callebaut 0.07 SWITZERLAND Daimler AG 0.66 GERMANY Ageas 0.09 BELGIUM BASF 0.64 GERMANY Danone 0.37 FRANCE Ahold Delhaize 0.26 NETHERLANDS Bayer AG 0.53 GERMANY Danske Bank A/S 0.1 DENMARK AIB Group 0.02 IRELAND Bechtle 0.04 GERMANY Dassault Aviation S.A.
    [Show full text]
  • Dividend and Compensation Payments in Light of Covid-19 Pandemic
    DIVIDEND AND COMPENSATION PAYMENTS IN LIGHT OF COVID-19 PANDEMIC Information as of 18 November 2020 Annual General Meeting 2019 dividend Company Index Short-time work Board compensation Executive compensation (2020) (paid 2020) ABB SMI unchanged (26.03.2020) unchanged CHF 0.80 - 10% reduction of board compensation for the duration of the 10% reduction of salary for the duration of the crisis crisis Adecco SMI unchanged (16.04.2020) unchanged CHF 2.50 yes - - Aevis Other unchanged (30.04.2020) cancelled - - - Alcon SMI unchanged (06.05.2020) postponed to 2021 - - - Also Other unchanged (24.03.2020) unchanged CHF 3.25 - - - ams SMIM unchanged (03.06.2020) - - - - APG/SGA Other unchanged (14.05.2020) cancelled (from CHF 11.00) yes - 20% reduction of base salary Aryzta Other postponed to 15.12.2020 postponed yes 30% reduction of fees for 3 months 30% reduction salary reduction for 3 months (15% for wider leadership team) Autoneum Other unchanged (25.03.2020) cancelled yes - 10% reduction of base salary Baloise SMIM unchanged (24.04.2020) unchanged CHF 6.40 - - - Barry Callebaut SMIM unchanged (09.12.2020) - - - - BB Biotech SMIM unchanged (19.03.2020) unchanged CHF 3.40 - - - Bobst Other unchanged (07.04.2020) unchanged CHF 1.50 - - - Bossard Other unchanged (08.04.2020) reduced by 50% to CHF 2.00 4% reduction of compensation 4% salary reduction Bucher Industries SMIM unchanged (24.04.2020) unchanged CHF 8.00 yes (mainly FR and IT) - - BVZ Other unchanged (16.04.2020) reduced to CHF 7.50 - - - Calida Group Other brought forward to cancelled
    [Show full text]
  • Results Zrating Study 2019 on Corporate Governance
    Zurich, 12 September 2019 Media release Results zRating Study 2019 on Corporate Governance Zürich, 12 September 2019 – Sunrise once again scores highest in this year’s corporate governance ranking followed by Swisscom (81 points) and Lonza (78 points). Due to amendments to the Articles of Association, also induced by activist shareholders, and changes in practices, companies have improved their corporate governance. For the eleventh time since 2009, the zRating Study on corporate governance in Swiss public companies has been published. zRating summarizes the situation regarding shareholders' rights in a company and draws attention to possible conflicts between shareholders and managers. zRating evaluates corporate governance holistically based on 62 criteria from the categories «Shareholders and Capital Structure», «Shareholders' Rights», «Composition Board of Directors/Management and Information Policy», and «Compensation and participation models». The criteria are weighted in a scoring model and evaluated with points. The total maximum of points is 100. 174 listed Swiss companies are analyzed based on Annual Reports 2018 and decisions at General Meetings 2019. Further improvements through amendments to the Articles of Association Once again Sunrise takes first place with 86 points. They had already gained a large lead thanks to amendments to the Articles of Association at the annual general meetings (AGM) in 2017 and 2018, and in 2019 Sunrise was also able to score in the new criteria. Second place went to Swisscom with 81 points and third place to Lonza with 78 points. This year, the boards of directors of Mobilezone, Peach Property and Starrag in particular proposed amendments to the Articles of Association that strengthened shareholders' participation rights.
    [Show full text]